HomeAI · summaries
Storia in 2 fonti
Astellas’ five-year plan includes chasing record sales and cost cuts
Astellas Pharma is aiming to double sales for its five key medicines, including Pfizer-partnered bladder cancer drug Padcev, through fiscal year 2030 under a new five-year strategy it published Tuesday.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable…
Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company
- ·
endpoints.news
Astellas’ five-year plan includes chasing record sales and cost cuts
Astellas Pharma is aiming to double sales for its five key medicines, including Pfizer-partnered bladder cancer drug Padcev, through fiscal year 2030 under a new five-year…